[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and Europe Checkpoint Inhibitors for Treating Cancer Market Status and Future Forecast 2013-2023

January 2018 | 114 pages | ID: GC5FFAE325FEN
99Strategy

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Key Content of Chapters (Including and can be customized)

Part 1: Market Overview, Development, and Segment by Type, Application & Region
Part 2: Global Market by company, Type, Application & Region
Part 3: Europe Market by company, Type, Application
Part 4-13: Key Regions of Europe Market by Type, Application
Part 14: Company information, Sales, Cost, Margin etc.
Part 15: Conclusion

Market Segment as follows:

By Region
  • Global (Europe, America, Asia etc.)
  • Europe (Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland, etc.)
Key Companies
  • Bristol-Myers Squibb(BMS)
  • Merck
  • Roche
Market by Type
  • PD-1 inhibitors
  • PD-L1 inhibitors
  • CTLA-4 inhibitors
Market by Application
  • Melanoma treatment
  • Bladder cancer treatment
  • Others
Table of Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 EUROPE MARKET STATUS AND FUTURE FORECAST

3.1 Europe Market by Region
3.2 Europe Market by Company
3.3 Europe Market by Type
3.4 Europe Market by Application
3.5 Europe Market by Forecast

PART 4 GERMANY MARKET STATUS AND FUTURE FORECAST

4.1 Germany Market by Type
4.2 Germany Market by Application
4.3 Germany Market by Forecast

PART 5 UK MARKET STATUS AND FUTURE FORECAST

5.1 UK Market by Type
5.2 UK Market by Application
5.3 UK Market by Forecast

PART 6 FRANCE MARKET STATUS AND FUTURE FORECAST

6.1 France Market by Type
6.2 France Market by Application
6.3 France Market by Forecast

PART 7 ITALY MARKET STATUS AND FUTURE FORECAST

7.1 Italy Market by Type
7.2 Italy Market by Application
7.3 Italy Market by Forecast

PART 8 RUSSIA MARKET STATUS AND FUTURE FORECAST

8.1 Russia Market by Type
8.2 Russia Market by Application
8.3 Russia Market by Forecast

PART 9 SPAIN MARKET STATUS AND FUTURE FORECAST

9.1 Spain Market by Type
9.2 Spain Market by Application
9.3 Spain Market by Forecast

PART 10 NETHERLANDS MARKET STATUS AND FUTURE FORECAST

10.1 Netherlands Market by Type
10.2 Netherlands Market by Application
10.3 Netherlands Market by Forecast

PART 11 TURKEY MARKET STATUS AND FUTURE FORECAST

11.1 Turkey Market by Type
11.2 Turkey Market by Application
11.3 Turkey Market by Forecast

PART 12 SWITZERLAND MARKET STATUS AND FUTURE FORECAST

12.1 Switzerland Market by Type
12.2 Switzerland Market by Application
12.3 Switzerland Market by Forecast

PART 13 OTHER REGIONS OF EUROPE MARKET STATUS AND FUTURE FORECAST

13.1 Other Regions of Europe Market by Type
13.2 Other Regions of Europe Market by Application
13.3 Other Regions of Europe Market by Forecast

PART 14 KEY COMPANIES

14.1 Bristol-Myers Squibb(BMS)
14.2 Merck
14.3 Roche

PART 15 CONCLUSION

LIST OF TABLES

Table TYPE OF CHECKPOINT INHIBITORS FOR TREATING CANCER
Table Application of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region, 2013-2017 (Million USD)
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Checkpoint Inhibitors for Treating Cancer Market by Company, 2013-2017 (Million USD)
Table Global Checkpoint Inhibitors for Treating Cancer Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table Global Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table Global Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Region, 2013-2017 (Million USD)
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Company, 2013-2017 (Million USD)
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table Europe Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Germany Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table Germany Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Germany Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table Germany Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table UK Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table UK Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table UK Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table UK Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table France Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table France Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table France Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table France Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Italy Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table Italy Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Italy Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table Italy Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Russia Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table Russia Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Russia Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table Russia Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Spain Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table Spain Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Spain Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table Spain Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Million USD)
Table Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Million USD)
Table Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Bristol-Myers Squibb(BMS) Information
Table Checkpoint Inhibitors for Treating Cancer Sales, Cost, Margin of Bristol-Myers Squibb(BMS)
Table Merck Information
Table Checkpoint Inhibitors for Treating Cancer Sales, Cost, Margin of Merck
Table Roche Information
Table Checkpoint Inhibitors for Treating Cancer Sales, Cost, Margin of Roche

LIST OF FIGURES

Figure Global Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2018
Figure Global Checkpoint Inhibitors for Treating Cancer Market Share by Region in 2018
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Share by Region in 2018
Figure Global Checkpoint Inhibitors for Treating Cancer Market Share by Region in 2017 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Share by Region in 2017 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Share by Company in 2017 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Share by Company in 2017 (Volume)
Figure Germany Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Germany Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Germany Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Germany Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure UK Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure UK Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure UK Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure UK Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure UK Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure UK Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure France Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure France Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure France Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure France Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure France Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure France Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure Italy Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure Italy Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure Italy Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Italy Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Italy Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Italy Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure Russia Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure Russia Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure Russia Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Russia Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Russia Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Russia Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure Spain Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure Spain Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure Spain Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Spain Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Spain Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Spain Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure Netherlands Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure Netherlands Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure Netherlands Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Netherlands Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Netherlands Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Netherlands Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure Turkey Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure Turkey Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure Turkey Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Turkey Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Turkey Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Turkey Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure Switzerland Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure Switzerland Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure Switzerland Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Switzerland Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Switzerland Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Switzerland Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)
Figure Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Million USD)
Figure Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market Share by Type in 2017 (Volume)
Figure Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Million USD)
Figure Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market Share by Application in 2017 (Volume)
Figure Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Million USD)
Figure Other Regions of Europe Checkpoint Inhibitors for Treating Cancer Market Forecast, 2018-2023 (Volume)


More Publications